State of Michigan Retirement System Cuts Stock Position in DaVita Inc. (NYSE:DVA)

State of Michigan Retirement System lessened its stake in shares of DaVita Inc. (NYSE:DVA) by 2.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,339 shares of the company’s stock after selling 300 shares during the quarter. State of Michigan Retirement System’s holdings in DaVita were worth $1,995,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the stock. JPMorgan Chase & Co. raised its stake in shares of DaVita by 17.8% during the third quarter. JPMorgan Chase & Co. now owns 609,076 shares of the company’s stock worth $99,846,000 after purchasing an additional 92,014 shares during the last quarter. KBC Group NV raised its position in DaVita by 0.8% in the fourth quarter. KBC Group NV now owns 316,155 shares of the company’s stock worth $47,281,000 after acquiring an additional 2,636 shares in the last quarter. BNP Paribas Financial Markets raised its position in DaVita by 23.9% in the third quarter. BNP Paribas Financial Markets now owns 292,039 shares of the company’s stock worth $47,874,000 after acquiring an additional 56,389 shares in the last quarter. Nordea Investment Management AB raised its position in DaVita by 4.9% in the fourth quarter. Nordea Investment Management AB now owns 264,535 shares of the company’s stock worth $39,712,000 after acquiring an additional 12,339 shares in the last quarter. Finally, FMR LLC raised its position in DaVita by 659.9% in the third quarter. FMR LLC now owns 177,406 shares of the company’s stock worth $29,082,000 after acquiring an additional 154,061 shares in the last quarter. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Stock Up 4.5 %

DaVita stock opened at $146.73 on Friday. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. DaVita Inc. has a fifty-two week low of $125.64 and a fifty-two week high of $179.60. The firm has a market capitalization of $11.74 billion, a price-to-earnings ratio of 13.66, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. The stock’s fifty day moving average is $159.43 and its two-hundred day moving average is $157.90.

DaVita (NYSE:DVA) last released its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Sanford C. Bernstein set a $184.00 price objective on DaVita in a research report on Friday, February 21st. Barclays increased their price objective on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. Finally, Cowen reiterated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, DaVita presently has a consensus rating of “Hold” and an average price target of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.